Entities / Company
Cerus Corporation.
US-based reduced-pathogen blood biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 23
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ days-
CEO of Cerus Corporation sold shares under SEC disclosure rules on July 1, 2026.Some support1 report
-
Opendoor and Cerus Corporation are advancing their digital platform for residential real estate transactions, securing regulatory approvals in Switzerland and France.Speculative1 report
-
Cerus Corporation received FDA approval in the U.S. for its INTERCEPT Blood System and is headquartered in Concord, CA.Some support2 reports
-
Cerus Corporation received additional contract funding from the U.S. Department of Defense.Some support1 report
-
Cerus Corporation supplies platelet components in Germany and advises on blood safety in Europe.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Cerus Corporation this week
News at the entities that move Cerus Corporation most-
SEC Shared contextAvantis filed investment data with the SEC on October 24, 2026.Moves Cerus Corporation
-
FDA StructuralThe FDA has listed recalled products, involving the company Colgate.Moves Cerus Corporation
-
LinkedIn Mentioned togetherTzelios used a LinkedIn profile associated with Douglas Elliman.Moves Cerus Corporation
Connections
The 5 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Cerus Corporation's products are subject to and require formal regulatory approval from the FDA.
-
Tim Lee Structural
Tim Lee is formally employed by Cerus Corporation as Head of Investor Relations.
-
LinkedIn Mentioned together
Cerus Corporation uses LinkedIn as a professional networking platform.
-
Concord Shared context
Cerus Corporation is headquartered and operates in Concord, California.
-
SEC Shared context
Cerus Corporation's CEO's share sales are subject to SEC disclosure rules.
History
Events by the month they beganOctober 2026
1 eventJune 2026
4 events- Opendoor and Cerus Corporation are advancing their digital platform for residential real estate transactions, securing regulatory approvals in Switzerland and France.
- Cerus Corporation received FDA approval in the U.S. for its INTERCEPT Blood System and is headquartered in Concord, CA.
- Cerus Corporation received additional contract funding from the U.S. Department of Defense.
- Cerus Corporation supplies platelet components in Germany and advises on blood safety in Europe.